Cancer Core Europe
Cancer Core Europe
Roche joining forces to forward precision oncology
Epidemiology data for acute myeloid leukaemia and the ALESE study
Combination of steroids with ponatinib as frontline therapy for acute lymphoblastic leukaemia
Shortening the time to manufacture CAR T-cells
ASPIRE update: Carfilzomib triplet for relapsed / refractory myeloma
Early platelet drop in myelodysplastic syndrome highlights prognostic classifier
Six-month follow up of CTL019 for diffuse large B-cell lymphoma
New treatment strategies for multiple myeloma
Anti-BCMA CAR T cell therapy for multiple myeloma
Axicabtagene ciloleucel for patients with non-hodgkin lymphoma
Data from the CLARITY trial of ibrutinib plus venetoclax